From physiology to function, Delve transforms raw wearable signals into validated, regulator-aligned digital measures you can trust in clinical development.
Explore the Endpoint LibraryWearable data is noisy, inconsistent, and device-dependent. Digital biomarkers solve this by applying validated algorithms, statistical models, and context-aware transformations that turn continuous sensor data into meaningful, clinical-grade measurements.
Delve enables sponsors to rapidly deploy, validate, and scale digital biomarkers aligned with FDA, EMA, and PMDA digital health technology frameworks.
Compare sensor-derived signals against gold-standard clinical tools to confirm feasibility.
Generate reproducible, device-agnostic algorithms with consistent sampling and signal quality.
Measurement accuracy, variance, reproducibility, and context-of-use verification for FDA/EMA review.
Delve supports a broad and continuously expanding catalog of digital biomarkers. Each is validated for physiological accuracy, sampling reliability, and clinical interpretability.
The future of endpoints is hybrid. Delve fuses wearable signals with ePRO triggers, symptom diaries, and clinician assessments to produce composite endpoints with richer explanatory power.
This is how Delve reveals the story behind every datapoint — the human experience inside the physiology.
Real-time HRV + symptom correlation predicted early toxicity signals.
Nocturnal respiratory patterns improved early exacerbation detection.
Gait speed and 6MWT digital equivalents aligned with clinician assessments.
See how validated digital endpoints can accelerate your next study.
Book a Demo